Details of the Drug

General Information of Drug (ID: DMOTHNK)

Drug Name

NB-001

Synonyms

NanoHPX; Herpes labialis therapy (NanoStat topical formulation), NanoBio; Herpes simplex virus type 1 (HSV-1) therapy (NanoStat topical formulation), NanoBio

Indication

Disease Entry	ICD 11	Status	REF
Multiple sclerosis	8A40	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C12H20N6O
Canonical SMILES: C1=NC(=C2C(=N1)N(C=N2)CCNCCCCCO)N
InChI: 1S/C12H20N6O/c13-11-10-12(16-8-15-11)18(9-17-10)6-5-14-4-2-1-3-7-19/h8-9,14,19H,1-7H2,(H2,13,15,16)
InChIKey: CVPTTZZCRDVGSU-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 2815031
CAS Number: 686301-48-4
TTD ID: D02UOZ

References

1	ClinicalTrials.gov (NCT01695187) NB-001 Treatment of Recurrent Herpes Labialis. U.S. National Institutes of Health.